Skip to main content
. 2023 Mar 14;10:1143485. doi: 10.3389/fmed.2023.1143485

TABLE 3.

Quantification of vaccinated and unvaccinated participants included in the study.

Variables N Total1 Azvudine (N = 1431) Placebo (N = 1381) P-value2
Participants 281 0.769
Vaccinated 248 248 (88%) 127 (89%) 121 (88%)
Not vaccinated 33 33 (12%) 16 (11%) 17 (12%)

1n (%); Median (IQR).

2Pearson’s chi-square test.